NCT04166227

Brief Summary

The aim of the proposed study is to perform a comparative pilot, randomized controlled trial of hip arthroscopy versus definitive total hip arthroplasty (THA) for the treatment of early hip osteoarthritis (Tönnis Grade 1-2) in patients between the ages of 40-60 years.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 12, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 18, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

4.6 years

First QC Date

November 12, 2019

Last Update Submit

March 12, 2026

Conditions

Keywords

Hip ScopeTotal Hip Replacement

Outcome Measures

Primary Outcomes (1)

  • Change in Hip Dysfunction and Osteoarthritis Outcome Score (HOOS)

    Subscales measuring Pain, Symptoms, Activity limitations daily living and Function in sport and recreation The outcome measure is transformed in a worst to best scale from 0 to 100, with 100 indicating no symptoms and 0 indicating extreme symptoms.

    6 weeks, 3, 6 and 12 months

Secondary Outcomes (11)

  • Change in International Hip Outcome Tool [iHOT]

    6 weeks, 3, 6 and 12 months

  • Change in Hip Outcome Score

    6 weeks, 3, 6 and 12 months

  • Change in Modified Harris Hip Score

    6 weeks, 3, 6 and 12 months

  • EQ-5D

    6 weeks, 3, 6 and 12 months

  • Cost Utilization

    6 weeks, 3, 6 and 12 months

  • +6 more secondary outcomes

Study Arms (2)

Hip Arthroscopy

ACTIVE COMPARATOR

Patients in the Hip Arthroscopy group will undergo arthroscopy in the supine position under general anesthesia, with all procedures performed by two subspecialty-trained hip arthroscopists. An algorithmic surgical approach will be utilized to sequentially address pathology in the central and peripheral compartments of the hip based on both preoperative imaging findings and intraoperative findings. Emphasis will be placed on labral preservation and refixation, with osseous decompression under fluoroscopic guidance.

Procedure: Hip Arthroscopy

Total Hip Arthroplasty

ACTIVE COMPARATOR

Patients randomized to the Total Hip Replacement (THR) group will undergo THR via a direct anterior approach. A slightly oblique skin incision measuring approximately 8 cm will be used, starting 3 cm distally and laterally to the anterosuperior iliac spine. The intervals between tensor fascia lata (TFL) and sartorius will be developed superficially, and between rectus femoris and gluteus minimus deeper. Capsulotomy will be performed. A double osteotomy of the femoral neck will be performed to facilitate removal of the head followed by traditional preparation of the acetabulum using an offset reamer and the acetabular component will be inserted. Next, the superior capsule will be released to elevate the femur to allow access to the femoral canal, followed by standard preparation by use of an offset broach and the stem will be implanted

Procedure: Total Hip Arthroplasty

Interventions

Patients in the Hip Arthroscopy group will undergo arthroscopy in the supine position under general anesthesia, with all procedures performed by two subspecialty-trained hip arthroscopists. An algorithmic surgical approach will be utilized to sequentially address pathology in the central and peripheral compartments of the hip based on both preoperative imaging findings and intraoperative findings. Emphasis will be placed on labral preservation and refixation, with osseous decompression under fluoroscopic guidance.

Hip Arthroscopy

Patients randomized to the Total Hip Replacement (THR) group will undergo THR via a direct anterior approach. A slightly oblique skin incision measuring approximately 8 cm will be used, starting 3 cm distally and laterally to the anterosuperior iliac spine. The intervals between tensor fascia lata (TFL) and sartorius will be developed superficially, and between rectus femoris and gluteus minimus deeper. Capsulotomy will be performed. A double osteotomy of the femoral neck will be performed to facilitate removal of the head followed by traditional preparation of the acetabulum using an offset reamer and the acetabular component will be inserted. Next, the superior capsule will be released to elevate the femur to allow access to the femoral canal, followed by standard preparation by use of an offset broach and the stem will be implanted

Total Hip Arthroplasty

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Between the ages of 40-60 years at the time of surgery.
  • Radiographic evidence of mild to moderate hip OA (Tönnis Gr 0 with MRI chondral wear, Tönnis Gr 1 and 2).
  • Patients must have completed ≥3 months of non-operative management with ongoing symptoms.

You may not qualify if:

  • Advanced OA, defined as \<2 mm joint space (Tönnis Gr 3) or those with acetabular or femoral head cysts.
  • Patients who are pregnant or may become pregnant around the time of surgery.
  • Prior arthroplasty of the contralateral hip.
  • Current or prior hip dysplasia (defined by a lateral centre edge angle of \<20 degrees).
  • Acetabular protrusio or coxa profunda, making arthroscopic access unsafe/unfeasible.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fraser Health

New Westminster, British Columbia, V3L 0E4, Canada

Location

Fowler Kennedy Sport Medicine Clinic and University Hospital

London, Ontario, N6A 3K7, Canada

Location

MeSH Terms

Conditions

Osteoarthritis, Hip

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Ryan Degen, MD, FRCSC

    Fowler Kennedy Sport Medicine Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopaedic Surgeon

Study Record Dates

First Submitted

November 12, 2019

First Posted

November 18, 2019

Study Start

October 1, 2020

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

March 17, 2026

Record last verified: 2026-03

Locations